BKV Corp
BKV NYSE Crude Petroleum & Natural Gas Financials FY2022–FY2025
Last close · Oct 23, 2026
$20.36
1.7%What BKV Corp does
No business description yet.
- Legal name
- BKV Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 6, 2026
- Accession · CIK
- 0001628280-26-015661
0001838406
Revenue and margins
BKV Corp had $1.1B of revenue in fiscal 2025, up 9.9% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew −32.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$24.7M in fiscal 2025, −2.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
BKV Corp returned — to shareholders in fiscal 2025. The diluted share count rose 21.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably BKV Corp can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $166M | $105M | $81.2M | $248M |
| Debt incl. finance leases | — | $579M | $859M | $1.1B |
| Net debt / EBITDA | — | 1.0x | 4.1x | 1.8x |
| Debt / equity | — | 0.4x | 0.6x | 0.6x |
| Current ratio | — | 0.8x | 1.0x | 0.9x |
| Quick ratio | — | 0.7x | 0.9x | 0.9x |
| Total assets | — | $2.7B | $3.1B | $3.9B |
| Total liabilities | — | $1.2B | $1.5B | $1.9B |
| Shareholders' equity | $1.0B | $1.3B | $1.5B | $2.0B |
| Net debt (− = net cash) | — | $474M | $778M | $890M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ | ✓ |
| Cash from operations exceeds net income | ✕ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✕ | ✕ |
| Current ratio rose | — | — | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — |
| Revenue rose relative to assets | — | — | ✕ | ✕ |
| F-score | — / 3 | — / 4 | 3 / 8 | 4 / 8 |
| Accruals ratio | — | −5.1% | −8.8% | −2.9% |
| Altman Z'' | — | 1.80 | 1.01 | 1.80 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.7B | $1.3B | $1.0B | $1.1B |
| Operating income | $305M | $241M | −$64.2M | $304M |
| Pretax income | $473M | $162M | −$176M | $225M |
| Income tax | $62.7M | $30.1M | −$42.4M | $36.9M |
| Net income | $410M | $124M | −$139M | $179M |
| Net income to common | — | $124M | −$139M | $178M |
| Diluted EPS | $6.62 | $1.92 | −$1.94 | $2.05 |
| Diluted shares | 0.06B | 0.06B | 0.07B | 0.09B |
| Cash flow | ||||
| Cash from operations | $349M | $260M | $115M | $280M |
| Capital expenditure | — | $202M | $105M | $305M |
| Free cash flow | — | $58.8M | $10.0M | −$24.7M |
| Depreciation and amortization | $130M | $256M | $256M | $197M |
| Stock-based compensation | $31.9M | $25.8M | $16.3M | $12.8M |
| Share buybacks | — | $0.6M | $0.0M | — |
| Dividends and buybacks | — | $0.6M | $0.0M | — |
| Balance sheet | ||||
| Cash and short-term investments | $166M | $105M | $81.2M | $248M |
| Total debt | — | $579M | $859M | $1.1B |
| Current assets | — | $312M | $235M | $511M |
| Current liabilities | — | $412M | $237M | $565M |
| Inventory | — | $9.9M | $20.1M | $20.0M |
| Goodwill | — | $18.4M | $18.4M | $18.4M |
| Total assets | — | $2.7B | $3.1B | $3.9B |
| Total liabilities | — | $1.2B | $1.5B | $1.9B |
| Shareholders' equity | $1.0B | $1.3B | $1.5B | $2.0B |
| Margins | ||||
| Operating margin | 18.3% | 18.5% | −6.2% | 26.6% |
| EBITDA margin | 26.2% | 38.2% | 18.5% | 43.9% |
| Net margin | 24.7% | 9.5% | −13.4% | 15.7% |
| FCF margin | — | 4.5% | 1.0% | −2.2% |
| Returns | ||||
| Return on capital | — | 11.1% | −2.2% | 8.8% |
| Return on capital employed | — | 10.6% | −2.2% | 9.0% |
| Return on equity | 39.6% | 10.6% | −9.9% | 10.3% |
| Return on assets | — | 4.6% | −4.8% | 5.1% |
| Return on tangible equity | 39.6% | 9.7% | −9.4% | 9.0% |
| Growth | ||||
| Revenue growth | — | −21.5% | −20.4% | 9.9% |
| Net income growth | — | −69.9% | −212.2% | — |
| EPS growth | — | −71.0% | −201.0% | — |
| FCF growth | — | — | −82.9% | −346.2% |
| Share count change | — | 3.9% | 10.7% | 21.8% |
| Financial health | ||||
| Net debt / EBITDA | — | 1.0x | 4.1x | 1.8x |
| Debt / equity | — | 0.4x | 0.6x | 0.6x |
| Current ratio | — | 0.8x | 1.0x | 0.9x |
| Quick ratio | — | 0.7x | 0.9x | 0.9x |
| Capital allocation | ||||
| Capex / revenue | — | 15.5% | 10.2% | 26.7% |
| Stock comp / revenue | 1.9% | 2.0% | 1.6% | 1.1% |
| Payouts / FCF | — | 1.0% | 0.0% | — |
| Quality scores | ||||
| Piotroski F-score | — | — | 3.0 | 4.0 |
| Altman Z'' | — | 1.8 | 1.0 | 1.8 |
| Accruals ratio | — | −5.1% | −8.8% | −2.9% |
Source: SEC EDGAR XBRL filings (CIK 0001838406). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
